基本素養 Basic Literacy

人文素養
Humanistic quality
公民素養
Civic literacy
社會關懷
Social participation
國際視野
Global outlook

核心能力 Competence

照顧病人的基本能力
Basic ability in clinical care
專業素養
在照顧病人的基本能力下培育基礎與臨床醫學研究的專業素養 轉譯醫學領域專業能力之養成
Professionalism
良好的溝通能力
具有溝通、協調、整合及進行跨領域團隊合作之能力 培養國際觀與外語之能力
Excellent communication skills
解決問題的方法
具備創新思考及獨力解決問題之能力。
Technique for Problem-solving
終身學習的態度
強化終身自我學習意願之能力。
Habit of lifelong learning

課程概述 Course Description

從基本的腫瘤免疫學開始,本課程更加側重於其在臨床癌症治療中的應用。我們將討論從常規BCG,IL-2等到各種癌症治療中的免疫檢查點抑製劑(ICI)的免疫腫瘤學藥物。我們將闡明潛在的組合用法-例如雙重ICI藥劑,ICI藥劑+抗VEGF標靶治療和ICI藥劑+免疫調節劑等等。除了PD-1 / PD-L1抑制劑,我們還將探討對未來潛在藥劑的看法,例如溶瘤病毒,NK細胞療法,腸道微生物群治療等。 最後,我們將邀請一些行業專家來演講,為將來的合作提供可能的平台。
Starting from basic tumor immunology, this course is more focused on its application in clinical cancer treatment. We will talk about Immuno-Oncology agents, from conventional BCG, IL-2, etc., to immune check-point inhibitors (ICI) in various cancer treatment. We will elucidate potential combo usage – such as dual ICI agents, ICI agent + anti-VEGF target and ICI agent + immunomodulating agents, etc. Beyond PD-1/PD-L1inhibitors, we will also explore our viewpoint to future potential agent, such as oncolytic virus, NK cell-based therapies, microbiota, etc. Finally, we will invite some experts from industry to provide the platform for cooperation in the future.

課程學習目標 Course Objectives

  • 了解臨床癌症治療中, 傳統及現今免疫治療的功效及副作用
  • 了解臨床癌症治療中, 免疫治療的預測有效因子及抗藥性
  • 了解臨床癌症治療中, 合併治療的重要性及未來的開發方向
  • 課程進度 Progress Description

    進度說明 Progress Description
    1Introduction
    2Basic Immunology (1)
    3Basic Immunology (2)
    4Clinical Immunotherapy: BCG, IL-2, dendritic cell, etc.
    5Combination Strategy for Immunotherapy (1)- radiotherapy, anti-angiogenesis, etc.
    6Combination Strategy for Immunotherapy (2)–to target microenvironment, bispecific antibody, etc.
    7Biomarkers and Resistance to Immunotherapy
    8Oncolytic virus and microbiota in immunotherapy
    9Immune checkpoint inhibitor in Urological cancer
    10Immune checkpoint inhibitor in Lung cancer
    11Immune checkpoint inhibitor in Head and Neck Cancer
    12Immune checkpoint inhibitor in Hepatocellular Carcinoma and Gastric cancer
    13DNA repair and Immune checkpoint inhibitor in Breast cancer/Ovarian cancer
    14Microsatellite instability and Immune checkpoint inhibitor in colon cancer and endometrial cancer
    15Virus and Immune checkpoint inhibitor in lymphoma and cervical cancer
    16Clinical Cell therapy
    17Adverse effects of Immunotherapy and its management
    18Students' report
     以上每週進度教師可依上課情況做適度調整。The schedule may be subject to change.

    有關課程其他調查 Other Surveys of Courses

    1.本課程是否規劃業界教師參與教學或演講? 否
    Is there any industry specialist invited in this course? How many times? No
    2.本課程是否規劃含校外實習(並非參訪)? 否
    Are there any internships involved in the course? How many hours? No
    3.本課程是否可歸認為學術倫理課程? 否
    Is this course recognized as an academic ethics course? In the course how many hours are regarding academic ethics topics? No
    4.本課程是否屬進入社區實踐課程? 否
    Is this course recognized as a Community engagement and Service learning course? Which community will be engaged? No